Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
USA – Bristol-Myers Squibb (BMS) announced that the first drug in a new class of cancer immunotherapies has been approved by US FDA as an initial treatment for advanced melanoma,…
Read More
UNITED KINGDOM – Merk & Co’s checkpoint inhibitor Keytruda, which has been available for three years through the Cancer Drugs Fund (CDF), has now been approved for routine NHS use…
Read More
USA – Zydus Cadila, a pharmaceutical company, has announced that it has received approval from the US Food and Drug Administration to market Decitabine injection, which is used to treat…
Read More
USA – FUJIFILM Diosynth Biotechnologies (FDB) and Istari Oncology have announced that they have reached an agreement for the manufacture of PVSRIPO, a viral immunotherapy being developed by Istari Oncology…
Read More